Article Text

Download PDFPDF
Letters
NICE clinical guideline 86. Coeliac disease: recognition and assessment of coeliac disease
  1. Hayley J Jones1,
  2. Justin T Warner2
  1. 1Undergraduate Office, Cardiff University Medical School, Cardiff, UK
  2. 2Department of Child Health, University Hospital of Wales, Cardiff, UK
  1. Correspondence to Dr Justin Warner, Department of Child Health, University of Wales Hospital, Cardiff CF14 4XN, UK; joneshj04{at}msn.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The recently published NICE guideline 86 (May 2009), ‘Recognition and assessment of coeliac disease’,1 recommends screening in ‘high risk’ populations such as children and young people with type 1 diabetes. However, due to lack of evidence and without expert consensus, a recommendation on repeat testing after diabetes diagnosis is not made. The NICE clinical guideline (2004), ‘Type 1 diabetes: diagnosis and management of type 1 diabetes in children and young people’,2 originally stated that coeliac disease screening should be performed at diagnosis …

View Full Text

Footnotes

  • Competing interests None.

  • Provenance Not commissioned; not externally peer reviewed.